LOW-VOLUME · FEMALE-LED
tetracycline Side Effects
tetracycline (also sold as Sumycin) is a LOW-VOLUME FAERS extract #500 of 524 by FAERS report count. Still opens on FEMALE-LED: 81% of sex-coded reports are female (465 F / 111 M).
Data updated 2026-05-15
- 741
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
tetracycline reporting skew - 81% of sex-coded reports are female (465 F / 111 M). Volume band LOW-VOLUME #500 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for tetracycline (Sumycin) (741 reports #500 of 524 by FAERS report count). 81% of sex-coded reports are female (465 F / 111 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
DRUG HYPERSENSITIVITY leads 151 of 741 reports
FEMALE-LED reporters · age peak 18-44
Female-led reporters (81% of sex-coded rows)
Age peak 18-44 (221 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (199 reports, 26.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| PNEUMONIA | 81 |
| MOBILITY DECREASED | 78 |
| PAIN IN EXTREMITY | 78 |
| NECK PAIN | 77 |
| INJURY | 70 |
| MUSCULAR WEAKNESS | 70 |
| FALL | 69 |
| GASTROOESOPHAGEAL REFLUX DISEASE | 67 |
| HEPATITIS | 67 |
| INFLAMMATION | 67 |
| BURSITIS | 66 |
| FINGER DEFORMITY | 66 |
| LIVER FUNCTION TEST INCREASED | 66 |
| FOLLICULITIS | 65 |
| HYPOAESTHESIA | 65 |
| WEIGHT INCREASED | 57 |
| WHEEZING | 57 |
| BACK INJURY | 56 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (268, 36.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| PNEUMONIA | 102 |
| PAIN IN EXTREMITY | 89 |
| MOBILITY DECREASED | 88 |
| NECK PAIN | 87 |
| HEPATITIS | 83 |
| FALL | 79 |
| INJURY | 79 |
| MUSCULAR WEAKNESS | 79 |
| GASTROOESOPHAGEAL REFLUX DISEASE | 76 |
| INFLAMMATION | 76 |
| BURSITIS | 74 |
| FOLLICULITIS | 74 |
| HYPOAESTHESIA | 74 |
| LIVER FUNCTION TEST INCREASED | 74 |
| FINGER DEFORMITY | 73 |
| WHEEZING | 66 |
| VOMITING | 64 |
| WEIGHT INCREASED | 64 |
How to read tetracycline FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 741 voluntary reports linked to tetracycline (Sumycin), 2004-2025. Death is listed on 199 (26.9%). Hospitalization appears on 268 (36.2%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and FEMALE-LED skew still differ by drug; not a complete safety profile.
Read with tetracycline
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 762 FAERS cases (Δ 21 heavier vs tetracycline); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 774 FAERS cases (Δ 33 heavier vs tetracycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 705 FAERS cases (Δ 36 lighter vs tetracycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(total_reports) peer at 799 FAERS cases (Δ 58 heavier vs tetracycline); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 35.3 pp vs tetracycline's DEATH-HEAVY): CASELOAD · HOSP-MID.
tetracycline stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.